Week 11 & 12 - Drug Delivery to The Brain Flashcards

1
Q

What is the purpose of the BBB

A

To maintain homeostasis of the CNS (brain and spinal cord)

  • Protects brain from blood-borne toxins + pathogens
  • Controls what can enter + leave the brain
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the main problems with drug delivery across the BBB

A

Establishing a conc. gradient (from blood across BBB)

  • Blood conc. is limited
    • can ↑ GI tract drug conc. by ↑ drug intake
    • BUT when drug diffuses from GIT to blood the conc. is ↓ due to constant blood flow (taking drug away)
  • DUE to LOW CONC. in BLOOD = gradient from blood to brain is LIMITED
    - even if BBB was permeable movement across BBB is limited
    - can NOT force drug out of blood + across BBB down conc. gradient
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the 4 main components of the BBB

These are physiological factors affecting drug delivery

A
  1. Special capillary construction
  2. Direct drainage to/from CSF
  3. Active Efflux Transporters (AETs)
  4. Metabolic / destructive enzymes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Explain how “special capillary construction” affects drug delivery across the BBB

A

Brain has a large network of capillaries surrounding it = good blood supply
- capillaries are very close together
- capillaires bring nutrients + remove metabolites from brain
- blood capillaries: endothelial cells are closer together = tight junctions (no large gaps) = not leaky

BBB (phospholipid bilayer) is flexible
- Polar / hydrophilic heads move = small pores are formed = how passive diffusion occurs
- Small, lipophillic molecules can diffuse through gap / pore

  • Capillary is connected to astrocytes (glial cells) which is connected to neurones
    Astrocytes:
    • repair damage to neurones + provide physical support
    • make tight junctions on capillary even tighter
    • release enzymes that destroy drug
    • AETs

NOTE:
- Large, hydrophilic drugs can NOT pass BBB (can only pass through large gaps in normal capillaries)
- Small (<450Da), lipophilic drugs can cross BBB
- Some drugs may reach capillaries but not pass it into brain / parenchyma due to size
- When have illness may need to reduce dose as tight junction may become leaky

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Explain how “direct drainage to/from CSF” affects drug delivery across the BBB

A

CSF circulates around the brain + spine
- removes drug + metabolites from brain tissues and INTO bloodstream
- found in subarachnoid space
- Produced in choroid plexus

  • CSF is leaky (some drug can pass through it)
    - drug molecules can pass to/from CSF via arachnoid granulation (point of contact with bloodstream / vessels)
    - also have 4 points of contact with brain tissue

NOTE:
- Rate of drug loss from CSF is faster than rate of drug absorption from blood vessels (to CSF)
- due to efflux transporters

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Explain how “Active Efflux Transporters (AETs)” affects drug delivery across the BBB

A

AETs pump drug molecule outside of brain cell back into blood (into venous sinus)
- requires energy (transporter converts ATP into ADP = energy produced)

AETs Found In:
- Astrocytes
- CSF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What drug properties affect its permeability across the BBB

A
  1. Size
    • MUST be SMALL (< 450Da)
    • in order to cross BBB by passive diffusion
  2. Nature
    • Must be LIPOPHILIC
  3. HBD
    • Must be <3
    • the less donors = more permeable drug will be through BBB
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How does diseases effect BBB permeability

A

Both types of stroke, brain tumors etc. can impair BBB and cause tight junctions to become leaky
- causes a change in expression in the network of proteins that hold the cells tightly together
- molecules that normally couldnt pass can now pass = hyperpermeable BBB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

List the 6 main transport mechanisms through the BBB

A
  1. Paracellular
    • through tight junctions between cells
  2. Transport proteins / transporters
    • found on plasma membrane of endothelal cells
    • ligand binds to receptor + is uptaken
    • NOTE: exploit these transporters to deliver drugs to brain
    • e.g. big, hydrophillic molecules
  3. Lipophillic diffusion
    • small, lipophillic molecules
  4. Receptor-mediated Transcytosis
    • molecule binds to receptor = complex forms = endocytosis occurs
    • complex vesicle taken into endothelial cell, passes through cell + exocytosis occurs
    • molecule is released into brain
  5. Adsorptive Transcytosis
    • occurs due to charge
    • positively charged molecule adsorbs to surface of negatively charged membrane
    • molecule is engulfed (endocytosis)
    • exocytosis of molecule
    • phosphate group of phospholipid bilayermembrane = -ive
  6. AETs / efflux pumps
    - removes drug out of brain (across BBB) into blood
    - known as ABC-binding cassette (ABC)
    - require energy (transporter converts ATP into ADP)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the strategies used to deliver hydrophillic drugs

A
  1. Conventional Strategies
  2. Unconventional Strategies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the 3 conventional pharmaceutical stratergies for enhancing drug delivery across the BBB

a.k.a. pharmaceutical / chemical

A
  1. REMOVE HYDROGEN bonding sites
    - makes drug less polar
  2. CONJUGATE drug to LIPID MOLECULES
    - add acyl (hydrocarbon) chains to drug
    - makes drug more lipophillic
    - CAUTION: can ↑ drug size
  3. Create a LIPID SOLUBLE PRODRUG
    - conjugate drug to lipophilic molecule = inactive prodrug
    - enzymes cleave lipophilic molceule = active prodrug formed

NOTE:
- Changes shouldnt alter drug action
- Changes shouldn’t increase drug size >450Da
- Can increase SE as increased permeation to other tissues (due to lipophilicity)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the 2 unconventional pharmaceutical stratergies for enhancing drug delivery across the BBB

A
  1. Transiet (temporary) Disruption of BBB
    (Opening tight junctions)
    • dangerous (homeostatsis of BBB can be impacted) BUT effective
      DONE VIA using:
      1. Vasoactives = vasodilation of arteries = leaky capillaires
      2. Hyperosmolar Mannitol = absorbs water from endothelial cell = cell shrinks = junctions open
  2. Advanced delivery systems
    - Blocking active efflux pumps (AET)
    - Invasive routes (ICV injection and IC implants)
    - Hijack special biology (nanocarriers and transport systems)
    - Nose to brain route
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Blocking AETs

Advanced delivery systems

A

CONJUGATE drug to a SECOND MOLECULE (= prodrug) to prevent loss of drugs from brain into blood
- many drugs are substrates for AETs
- BUT when conjugated AETs UNABLE to RECOGNISE the prodrug = drug is able to remain in brain for longer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Explain the 2 “Invasive routes”

Advanced delivery systems

A
  1. Intracerebroventricular Injections (ICV)
    • introduces drug into ventricles in CSF or parenchyma
    • used in brain tumours, cancers
      DRAWBACKS:
      • Have metabolic enzymes in CSF = drug metabolised
      • Have efflux pumps in CSF = drug pumped back into blood (into venous sinus)
      • Have extra barrier lining the ventricles (lipiad gilal sheaths)
      • Diffusion from CSF to brain is much slower than diffusion from CSF into blood
  2. Intracerebal Implants
    • implant directly into parenchyma
    • used for altered cells (deliver drugs to surrounding cells)
      - e.g. to prevent reoccurance of cancer in safety margin (healthy tissue surrounding mass) after surgical removal of a tumour mass
    • can be matrix or reservoir (slow release of drug)
      DRAWBACKS:
      • Parenchymal bleeding
      • Poor diffusion of drug from implant to parenchyma
      • Metabolic enyzmes
      • Efflux pumps
      • Implant could migrate to ventricles = CSF becoems leaky
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the 2 ways to “Hijack special biology”

Advanced delivery systems

A
  1. Exploit transport systems
    • some nutrients e.g. amino acids are taken up by LAT1 transporters into brain
    • drugs like L-dopa have similar structure to amino acid = can be taken up via this transporter
      DONE VIA:
      1. DESIGN DRUG that has SIMILAR STRUCTURE to natural NUTRIENT
      2. CONJUGATE natural NUTRIENT to DRUG
      3. CONJUGATE drug to large carrier molecule (e.g. mAb, peptides) which targets receptror e.g. TfR (for large hydrophillics)
        - conjugated with weak conavlent bonds (disulfide ~ S-S) = after drug is uptaken it can be cleaved + released
  2. Nanocarriers
    ACTIVE TARGETTING:
    - drug is loaded inside core of drug-carrying liposome
    - ligand / molecule (e.g. mAb) is conjugated to liposome / nanocarrier
    - ligand binds to receptor = endocytosis of entire structure
    PASSIVE TARGETTING:
    (only in cancer)
    - if have tumour = impaired capillaires = big gaps
    - gaps allow nanoparticle through
    - in healthy capillaries nanoparticle would NOT be able to pass
    - cancer vasculature have enhanced permation + retention (due to inefficent lymphatic drainage system) = drug will remain there for long time
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Cancer vasculature vs normal vasculature

Nanocarriers

A

Cancer vasculature:
- newly formed, disordered, fragile and immature blood vessesls
- vessels are leaky = big particles can be uptaken

Normal Vasculature:
- ordered, intact, mature bloof vessels
- vessels are supported + stabilised by smooth muscle = no big particles can pass through

17
Q

Nose to brain routes

Advanced delivery systems

A

Drug can be uptake from nasal cavity via NEUROLOGICAL PATHWAYS
- have NEURONES in NASAL CAVITY that CONNECT directly to OLFACTORY BULB (bottom of brain) or TRIGEMINAL NERVE
- drug passes through nasal nerve endings + connects to brain (bulb)

BEFORE drug reaches brain:
1. pass through olfactory epithelial cells
- either via, paracellular (junctions), transcellular (receptor trancytosis or passive diffusion)
2. arachnoid membrane

Characteristics of Nanoparticles used via olfactory route:
- Non-toxic, biodegreadable
- Mucoadhesive (adhere to nasal mucosa)
- Open tight junctions in nasal cavity
- Targetting using ligands